Clinical Trial Update: INHERIT EGFR - Studying Germline EGFR Mutations

View source ↗

Summary

This entry reports on the INHERIT EGFR study investigating germline EGFR mutations in lung cancer patients. The trial (NCT01754025) is sponsored by Dana-Farber …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer | Status: ACTIVE_NOT_RECRUITING